OTC chlamydia test
This article was originally published in The Tan Sheet
Antioch, Calif.-based Zonda intends to eventually seek approval to market itsHandiLab-C over-the-counter chlamydia test in the U.S., according to a spokesperson for CLX Investment, which holds 31% equity interest in the California firm. Currently, the HandiLab-C test is the only OTC test for chlamydia that carries the CE mark, which signifies the product complies with relevant European Union health, safety and environmental protection requirements, according to CLX. Zonda recently entered into a distribution agreement to introduce the test in Turkey, according to a Sept. 19 release from CLX. "In fairly short order, we expect that the HandiLab-C will be found on pharmacy shelves in virtually every country in Europe," CLX Chairman and CEO Robert McCoy says...
You may also be interested in...
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.